SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-18-162350
Filing Date
2018-05-14
Accepted
2018-05-14 15:08:32
Documents
3
Group Members
SPECTRUM PHARMACEUTICALS CAYMAN, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d576112dsc13da.htm SC 13D/A 88741
2 EX-24.1 d576112dex241.htm EX-24.1 14709
3 EX-99.1 d576112dex991.htm EX-99.1 7828
  Complete submission text file 0001193125-18-162350.txt   113219
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filed by) CIK: 0000831547 (see all company filings)

IRS No.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Subject) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-46247 | Film No.: 18830192
SIC: 2836 Biological Products, (No Diagnostic Substances)